Cargando…

Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report

BACKGROUND: Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell death protein-1, and anti-cytotoxic T-lymphocyte-associated protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimodaira, Yosuke, Takahashi, So, Iijima, Katsunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105910/ https://www.ncbi.nlm.nih.gov/pubmed/33964871 http://dx.doi.org/10.1186/s12876-021-01803-8

Ejemplares similares

Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan
por: Shimodaira, Yosuke, et al.
Publicado: (2021)

Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding
Publicado: (1996)

The Combination of Dupilumab with Other Monoclonal Antibodies
por: Gisondi, P., et al.
Publicado: (2022)

Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from Rheumatoid arthritis patients
por: Santos Savio, Alicia, et al.
Publicado: (2015)

Nature and Clinical Outcomes of Acute Hemorrhagic Rectal Ulcer
por: Takahashi, Yasutaka, et al.
Publicado: (2022)

Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis
por: Papageorgis, Panagiotis, et al.
Publicado: (2015)

The risk of antibiotics and enterocolitis for the development of inflammatory bowel disease: a Japanese administrative database analysis
por: Shimodaira, Yosuke, et al.
Publicado: (2022)

Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
por: Greinacher, Andreas, et al.
Publicado: (2021)

Enhanced STAT3 phosphorylation and PD-L1 expression in myeloid dendritic cells indicate impaired IL-27Ralpha signaling in type 1 diabetes
por: Parackova, Z., et al.
Publicado: (2020)

Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis
por: Iizuka, Masahiro, et al.
Publicado: (2021)

Development of a Novel, Anti-idiotypic Monoclonal Anti-prolactin Antibody That Mimics the Physiological Functions of Prolactin
por: Wang, Meng, et al.
Publicado: (2016)

Treatment of Refractory Prurigo Nodularis with a Monoclonal Antibody Dupilumab with Surprising Clinical Response
por: Alves, Juliana P., et al.
Publicado: (2023)

Exploratory Population PK Analysis of Dupilumab, a Fully Human Monoclonal Antibody Against IL‐4Rα, in Atopic Dermatitis Patients and Normal Volunteers
por: Kovalenko, P, et al.
Publicado: (2016)

Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis
por: Boden, Elisa K, et al.
Publicado: (2019)

Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis
por: Kierkus, Jaroslaw, et al.
Publicado: (2020)

Human Neutrophil Elastase Proteolytic Activity in Ulcerative Colitis Favors the Loss of Function of Therapeutic Monoclonal Antibodies
por: Curciarello, Renata, et al.
Publicado: (2020)

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
por: Le Floc’h, Audrey, et al.
Publicado: (2020)

Treatment with a Monoclonal Anti-IL-12p40 Antibody Induces Substantial Gut Microbiota Changes in an Experimental Colitis Model
por: Castro-Mejía, Josué, et al.
Publicado: (2016)

Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis
por: Kierkus, Jaroslaw, et al.
Publicado: (2020)

Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study
por: Sakai, Masahiro, et al.
Publicado: (2023)

Ulcerative injection-site reaction associated with dupilumab therapy
por: Phan, Michael, et al.
Publicado: (2020)

Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma
por: Chiu, Yi-Shu, et al.
Publicado: (2017)

Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
por: Pangilinan, Mary Catherine G., et al.
Publicado: (2020)

The Effects of Armillarisin A on Serum IL-1β and IL-4 and in Treating Ulcerative Colitis
por: Wu, Ping, et al.
Publicado: (2014)

Evaluation of anti-ulcer and ulcerative colitis of Sonchus oleraceus L
por: Alothman, Esraa A., et al.
Publicado: (2018)

Anti-cyclic citrullinated peptide antibodies in ulcerative colitis, and its relation with disease activity
por: Shafaghi, Afshin, et al.
Publicado: (2014)

Protective effect of TSLP and IL-33 cytokines in ulcerative colitis
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2019)

Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis
por: Sandborn, W. J., et al.
Publicado: (2016)

Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II
por: Reinisch, Walter, et al.
Publicado: (2021)

Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
por: Xu, Jiuhui, et al.
Publicado: (2023)

Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
por: Ganesan, Rajkumar, et al.
Publicado: (2017)

Usefulness of the CHAMPS score for risk stratification in lower gastrointestinal bleeding
por: Tajika, Munehiko, et al.
Publicado: (2022)

Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis
por: Li, Gavin, et al.
Publicado: (2020)

Ulcerative colitis in the postpartum period
por: Chiba, Mitsuro, et al.
Publicado: (2020)

Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
por: Kariyawasam, Harsha H, et al.
Publicado: (2020)

Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab
por: Piazzetta, Giovanna Lucia, et al.
Publicado: (2023)

Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures
por: Shome, Mahasish, et al.
Publicado: (2022)

Anti-proteinase 3 antineutrophil cytoplasmic antibody reflects disease activity and predicts the response to steroid therapy in ulcerative colitis
por: Aoyama, Yuki, et al.
Publicado: (2021)

Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report
por: Reyes, Carmen Mota, et al.
Publicado: (2023)

Anti-IL-20 monoclonal antibody promotes bone fracture healing through regulating IL-20-mediated osteoblastogenesis
por: Hsu, Yu-Hsiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gfctcgim3ruf2idlk478tqs91e